To help organizations better comply with the updated national patient safety goal on reducing harm linked to anticoagulant therapy, the accrediting organization describes its national patient safety goal for anticoagulant therapy in a new report.
The patient safety goal will include eight performance elements (specific actions, processes or structures) that must be implemented to achieve the goal. The performance elements are applicable to all Joint Commission-accredited hospitals, critical access hospitals, nursing care centers and medical centers.
Healthcare organizations will be required to use approved protocols and evidence-based guidelines for:
- Initiating and maintaining anticoagulant therapy
- Reversing anticoagulation and managing bleeding events linked to each medication
- Managing all patients on oral anticoagulants perioperatively
Organizations will also be required to have a written policy addressing the need for ongoing laboratory tests to monitor anticoagulant therapy and educate patients/families on blood-thinning medication prescribed.
More articles on clinical leadership and infection control:
Machine learning can help predict hospital infection risk, study finds
Stamford Hospital fined for running blood center without certification
Can vitamin-steroid cocktail cure sepsis? Trial aims to find out
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
